N-methyl-D-aspartate receptor antibody encephalitis: how do we evaluate symptomatic treatment?

Jonathan Gadian¹, Ming Lim^{1

2}

Affiliations

¹ Children's Neurosciences, Evelina London Children's Hospital at Guy's & St Thomas' NHS Trust, Kings Health Partners Academic Health Science Centre, London, UK.
² Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.

Free article

Comment

Jonathan Gadian et al. Dev Med Child Neurol. 2016 Apr.

Free article

. 2016 Apr;58(4):325-6.

doi: 10.1111/dmcn.12940. Epub 2015 Oct 12.

Jonathan Gadian¹, Ming Lim^{1

2}

¹ Children's Neurosciences, Evelina London Children's Hospital at Guy's & St Thomas' NHS Trust, Kings Health Partners Academic Health Science Centre, London, UK.
² Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.

No abstract available

Comment on

Symptomatic treatment of children with anti-NMDAR encephalitis.
Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai SC, Brilot F, Dale RC. Mohammad SS, et al. Dev Med Child Neurol. 2016 Apr;58(4):376-84. doi: 10.1111/dmcn.12882. Epub 2015 Aug 28. Dev Med Child Neurol. 2016. PMID: 26330176